Logo image of ZOMD.CA

ZOOMD TECHNOLOGIES LTD (ZOMD.CA) Stock Fundamental Analysis

TSX-V:ZOMD - TSX Venture Exchange - CA98981L1004 - Common Stock - Currency: CAD

0.66  0 (0%)

Fundamental Rating

5

Overall ZOMD gets a fundamental rating of 5 out of 10. We evaluated ZOMD against 66 industry peers in the Software industry. ZOMD has an excellent financial health rating, but there are some minor concerns on its profitability. ZOMD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ZOMD was profitable.
ZOMD had a positive operating cash flow in the past year.
ZOMD had negative earnings in 4 of the past 5 years.
In multiple years ZOMD reported negative operating cash flow during the last 5 years.
ZOMD.CA Yearly Net Income VS EBIT VS OCF VS FCFZOMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

ZOMD's Return On Assets of 23.85% is amongst the best of the industry. ZOMD outperforms 98.48% of its industry peers.
With an excellent Return On Equity value of 39.82%, ZOMD belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
With an excellent Return On Invested Capital value of 24.91%, ZOMD belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
Industry RankSector Rank
ROA 23.85%
ROE 39.82%
ROIC 24.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZOMD.CA Yearly ROA, ROE, ROICZOMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

ZOMD has a better Profit Margin (12.40%) than 87.88% of its industry peers.
ZOMD has a Operating Margin of 13.38%. This is amongst the best in the industry. ZOMD outperforms 80.30% of its industry peers.
The Gross Margin of ZOMD (38.16%) is comparable to the rest of the industry.
ZOMD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.38%
PM (TTM) 12.4%
GM 38.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
ZOMD.CA Yearly Profit, Operating, Gross MarginsZOMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

7

2. Health

2.1 Basic Checks

ZOMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ZOMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ZOMD.CA Yearly Shares OutstandingZOMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
ZOMD.CA Yearly Total Debt VS Total AssetsZOMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.51 indicates that ZOMD is not in any danger for bankruptcy at the moment.
ZOMD has a Altman-Z score of 4.51. This is in the better half of the industry: ZOMD outperforms 75.76% of its industry peers.
The Debt to FCF ratio of ZOMD is 0.59, which is an excellent value as it means it would take ZOMD, only 0.59 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.59, ZOMD belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that ZOMD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.22, ZOMD is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.59
Altman-Z 4.51
ROIC/WACC2.12
WACC11.74%
ZOMD.CA Yearly LT Debt VS Equity VS FCFZOMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ZOMD has a Current Ratio of 1.89. This is a normal value and indicates that ZOMD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ZOMD (1.89) is better than 71.21% of its industry peers.
ZOMD has a Quick Ratio of 1.89. This is a normal value and indicates that ZOMD is financially healthy and should not expect problems in meeting its short term obligations.
ZOMD has a Quick ratio of 1.89. This is in the better half of the industry: ZOMD outperforms 71.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.89
ZOMD.CA Yearly Current Assets VS Current LiabilitesZOMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M

4

3. Growth

3.1 Past

ZOMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 188.57%, which is quite impressive.
The Revenue has grown by 32.81% in the past year. This is a very strong growth!
The Revenue has been growing by 8.10% on average over the past years. This is quite good.
EPS 1Y (TTM)188.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
Revenue 1Y (TTM)32.81%
Revenue growth 3Y8.1%
Revenue growth 5YN/A
Sales Q2Q%134.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZOMD.CA Yearly Revenue VS EstimatesZOMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ZOMD.CA Yearly EPS VS EstimatesZOMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

5

4. Valuation

4.1 Price/Earnings Ratio

ZOMD is valuated reasonably with a Price/Earnings ratio of 8.25.
95.45% of the companies in the same industry are more expensive than ZOMD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.35. ZOMD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.25
Fwd PE N/A
ZOMD.CA Price Earnings VS Forward Price EarningsZOMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

92.42% of the companies in the same industry are more expensive than ZOMD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ZOMD is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.73
EV/EBITDA 4.64
ZOMD.CA Per share dataZOMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

ZOMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZOMD!.
Industry RankSector Rank
Dividend Yield N/A

ZOOMD TECHNOLOGIES LTD

TSX-V:ZOMD (3/7/2025, 7:00:00 PM)

0.66

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners22.15%
Ins Owner ChangeN/A
Market Cap65.45M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE N/A
P/S 0.97
P/FCF 7.73
P/OCF 7.62
P/B 3.12
P/tB 5.98
EV/EBITDA 4.64
EPS(TTM)0.08
EY12.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.09
FCFY12.94%
OCF(TTM)0.09
OCFY13.12%
SpS0.68
BVpS0.21
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 23.85%
ROE 39.82%
ROCE 38.89%
ROIC 24.91%
ROICexc 39.94%
ROICexgc 104.28%
OM 13.38%
PM (TTM) 12.4%
GM 38.16%
FCFM 12.58%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
F-Score8
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.59
Debt/EBITDA 0.36
Cap/Depr 3.33%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 68.95%
Profit Quality 101.48%
Current Ratio 1.89
Quick Ratio 1.89
Altman-Z 4.51
F-Score8
WACC11.74%
ROIC/WACC2.12
Cap/Depr(3y)3.34%
Cap/Depr(5y)3.08%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)188.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.81%
Revenue growth 3Y8.1%
Revenue growth 5YN/A
Sales Q2Q%134.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y310.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.92%
OCF growth 3YN/A
OCF growth 5YN/A